<?xml version="1.0" encoding="UTF-8"?>
<ref id="B201-nutrients-10-01662" class="ref">
 <label class="label">201.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Lopez-Toledano</surname>
    <given-names class="given-names">M.A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Thorsteinsson</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Daak</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Maki</surname>
    <given-names class="given-names">K.C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Johns</surname>
    <given-names class="given-names">C.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rabinowicz</surname>
    <given-names class="given-names">A.L.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sancilio</surname>
    <given-names class="given-names">F.D.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">A Novel ω-3 acid ethyl ester formulation incorporating Advanced Lipid Technologies™ (ALT
   <sup class="sup">®</sup>) improves docosahexaenoic acid and eicosapentaenoic acid bioavailability compared with Lovaza
   <sup class="sup">®</sup>
  </article-title>
  <source class="source">Clin. Ther.</source>
  <year class="year">2017</year>
  <volume class="volume">39</volume>
  <fpage class="fpage">581</fpage>
  <lpage class="lpage">591</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.clinthera.2017.01.020</pub-id>
  <?supplied-pmid 28189364?>
  <pub-id pub-id-type="pmid" class="pub-id">28189364</pub-id>
 </element-citation>
</ref>
